Stay updated on Depemokimab in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.4.2 has been added in place of v3.4.1.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now shows a glossary and the last QC-update label has been changed to 'Last Update Submitted that Met QC Criteria'. Revision metadata has been updated to 'Revision: v3.4.0' (replacing the previous v3.3.4) and 'No FEAR Act Data' capitalization adjusted.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.3.4 is now shown, replacing the previous v3.3.3 on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded a publication entry related to the study, including a PubMed note for a related article (Safety and Tolerability of Twice-Yearly Depemokimab...). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a comprehensive Locations section listing trial sites by state/province (US, Australia, Canada) and updated the page to Revision: v3.3.3. Removed the prior v3.3.2 entries, including the old location listings and the HHS Vulnerability Disclosure link.SummaryDifference1%

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.